Mark Fielden

Mark Fielden, a Ph.D. graduate from Michigan State University in Toxicology, Biochemistry, and Molecular Biology, has held various senior positions in companies such as Kate Therapeutics, Expansion Therapeutics, Amgen, Hoffmann-LaRoche, Ltd., and Iconix Biosciences.